Vivos Inc (RDGL) SEC filings

RDGLOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 9/30

$0.05−0.00 (-2.51%)

Close on Oct 19, 2026Market cap $23.61MP/E –Yield –

SEC filings

40 of Vivos's most recent filings on SEC EDGAR

Document	Form	Period	Filed	Source
Quarterly report	10-Q	Sep 30, 2026	Nov 12, 2026	SEC EDGAR
Proxy statement	DEF 14A	Nov 9, 2026	Nov 9, 2026	SEC EDGAR
Current report	8-K	Oct 30, 2026	Nov 5, 2026	SEC EDGAR
Current report	8-K	Oct 7, 2026	Oct 8, 2026	SEC EDGAR
Current report	8-K	Sep 28, 2026	Oct 5, 2026	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2026	Aug 12, 2026	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2026	May 14, 2026	SEC EDGAR
Annual report	10-K	Dec 31, 2025	Mar 31, 2026	SEC EDGAR
Quarterly report	10-Q	Sep 30, 2025	Nov 12, 2025	SEC EDGAR
Current report	8-K	Sep 15, 2025	Sep 22, 2025	SEC EDGAR
Current report	8-K	Sep 17, 2025	Sep 18, 2025	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2025	Aug 13, 2025	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2025	May 9, 2025	SEC EDGAR
Annual report	10-K	Dec 31, 2024	Mar 24, 2025	SEC EDGAR
Current report	8-K	Feb 4, 2025	Feb 10, 2025	SEC EDGAR
Current report	8-K	Feb 6, 2025	Feb 10, 2025	SEC EDGAR
Quarterly report	10-Q	Sep 30, 2024	Nov 13, 2024	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2024	Aug 13, 2024	SEC EDGAR
Current report	8-K	Jun 28, 2024	Jul 1, 2024	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2024	May 9, 2024	SEC EDGAR
Current report	8-K	Dec 19, 2023	Mar 25, 2024	SEC EDGAR
Annual report	10-K	Dec 31, 2023	Mar 18, 2024	SEC EDGAR
Current report	8-K	Dec 22, 2023	Dec 27, 2023	SEC EDGAR
Quarterly report	10-Q	Sep 30, 2023	Nov 6, 2023	SEC EDGAR
Current report	8-K	Oct 10, 2023	Oct 11, 2023	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2023	Aug 4, 2023	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2023	May 4, 2023	SEC EDGAR
Current report	8-K	May 1, 2023	May 2, 2023	SEC EDGAR
Annual report	10-K	Dec 31, 2022	Mar 1, 2023	SEC EDGAR
Quarterly report	10-Q	Sep 30, 2022	Oct 19, 2022	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2022	Jul 25, 2022	SEC EDGAR
Current report	8-K	Jul 7, 2022	Jul 11, 2022	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2022	May 10, 2022	SEC EDGAR
Annual report	10-K	Dec 31, 2021	Mar 7, 2022	SEC EDGAR
Current report	8-K	Jan 24, 2022	Jan 27, 2022	SEC EDGAR
Quarterly report	10-Q	Sep 30, 2021	Oct 25, 2021	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2021	Aug 2, 2021	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2021	May 10, 2021	SEC EDGAR
Current report	8-K	May 7, 2021	May 7, 2021	SEC EDGAR
Annual report	10-K	Dec 31, 2020	Mar 24, 2021	SEC EDGAR

Where these numbers come from

Parsed from the XBRL in Vivos's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-8 reverse split on Jun 28, 2019
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is RDGL.

Compare: RDGL vs PAVM · RDGL vs GUTS · RDGL vs PFSA · RDGL vs GIPL · RDGL vs PETV

Revenue growth159.4% · median -49.3%

Gross margin6.8% · median -76.8%

Operating margin-2414.0% · median -2157.4%

Net margin-3032.9% · median -2157.4%

Company	Revenue	Growth
PETV	$1.18M	-9.5%
RDGL	$126.12K	+159.4%
PAVM	$112.00K	-89.0%
GIPL	$30.00K	–
GUTS	–	–
PFSA	–	–

Company

Exchange: OTC
Industry: Surgical & Medical Instruments & Apparatus
Fiscal year ends: December 31
Employees: 1
Auditor: Fruci & Associates II, PLLC
SEC CIK: 1449349

Advertisement
300 × 250

See a number that looks wrong?